FIELD: medicine.
SUBSTANCE: method involves introducing 1 ml of combined 2% hydrogel Chytosane ascorbate solution of 94-98% deacetylation degree as single dose into Tennon space to posterior eye pole. Molecular mass is equal to 100-700 kDa. 1 l of the solution contains 200 mg of hyaluronic acid, 2 g of chondroitin sulfuric acid, 110-440 mcg of cattle serum growth factor and 50 mg of heparin.
EFFECT: enhanced effectiveness of treatment; substituting hydrogel with proper connective tissue reach in newly formed blood vessels.
1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATMENT OF DIABETIC RETINOPATHY WITH PREPARATION "BOL-KHIT" | 2006 |
|
RU2301675C1 |
| METHOD FOR TREATING DEGENERATIVE MYOPIA | 2006 |
|
RU2308952C1 |
| METHOD FOR GLAUCOMA TREATMENT WITH NON-STABILIZED VISUAL FUNCTIONS | 2005 |
|
RU2299732C1 |
| METHOD FOR PROPHYLAXIS OF MYOPIA PROGRESSING | 2005 |
|
RU2275917C1 |
| METHOD FOR TREATMENT OF CENTRAL ATHEROSCLEROTIC CHORIORETINOPATHY | 2005 |
|
RU2281775C1 |
| METHOD FOR TREATING THE CASES OF OPTIC NERVE ATROPHY | 1998 |
|
RU2171099C2 |
| METHOD OF TREATING DYSTROPHIC DISEASES OF POSTERIOR EYE POLE | 2010 |
|
RU2435556C1 |
| METHOD FOR TREATING DYSTROPHIC DISEASES OF EYES | 2000 |
|
RU2195297C2 |
| METHOD FOR TREATING UVEITIS IN CHILDREN | 1999 |
|
RU2185193C2 |
| SURGICAL METHOD FOR TREATING THE CASES OF VASCULAR DISEASES OF INTERNAL EYE TUNICS | 2004 |
|
RU2289371C2 |
